Clinical Trials in Pennsylvania

Showing 12421-12440 of 19,675 trials

Using an End-of-life Conversation Game to Engage Underserved Communities in Advance Care Planning

NCT03456921

This national project will provide an effective, evidence-based intervention for advance care planning (ACP) to 50 underserved US communities, those with poor access to healthcare systems due to economic, cultural or other barriers. The project will also examine 15 of the 50 communities to learn about the unique needs of African American communities in regards to ACP and to assess the intervention with this population. The team includes the Hospice Foundation of America and a university-based research team from Penn State Milton S. Hershey Medical Center.

Advance Care PlanningVulnerable PopulationsAdvance Directives+1 more

Milton S. Hershey Medical Center1,122 participantsStarted Feb 2018

Hershey, Pennsylvania, United States

COMPLETEDPhase 236 miles

Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

NCT01836029

The purpose of this study is to compare the progression-free survival of patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) treated with VTX-2337 + cisplatin or carboplatin + 5-FU + cetuximab versus patients treated with cisplatin or carboplatin + 5-FU + cetuximab alone (standard-of-care; SOC). Safety and overall survival will also be evaluated.

Carcinoma, Squamous Cell of Head and Neck

Celgene195 participantsStarted Oct 2013

Little Rock, Arkansas, United States • Beverly Hills, California, United States • Escondido, California, United States +50 more locations

Using an End-of-life Conversation Game to Engage Underserved Communities in Advance Care Planning

Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Find Trials by Condition in Pennsylvania

Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma

Trial of Lithium Carbonate for Treatment of Osteoporosis-pseudoglioma Syndrome

Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma

A Phase I Study to Assess the Safety, Pharmacokinetics, and Potential Effects of Amrubicin on the QT/QTc Interval in Cancer Patients With Advanced Solid Tumors.

Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission

0822GCC: Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer

Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic Adenocarcinoma

Evaluation of the Archimedes™ System for Transparenchymal Nodule Access 2

A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL)

Expanded Access For Lorlatinib For Patients With Non Small Cell Lung Cancer ALK Positive or ROS1 Positive

SPRINT - Randomized Trial of Tibial Fracture Fixation

A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine

A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066

Study in Subjects With Moderate Atopic Dermatitis

Sickle Cell Anemia - A Comparative Study Between Three Ethnical Communities, a Multicenter Study

A Safety and Pharmacokinetic Study of TAK-228 in Combination With TAK-117 in Adult Participants With Advanced Nonhematologic Malignancies

Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects

Estimating Average Vitamin A Requirements in Indonesian and American Women